Synta Pharmaceuticals, Inc. (SNTA) Posts Q2 Loss of 33c/Share
Tweet Send to a Friend
Synta Pharmaceuticals, Inc. (NASDAQ: SNTA) reported Q2 EPS of ($0.33), $0.03 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
